Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Botulinum Toxin: An Update on Pharmacology and Newer Products in Development

Lookup NU author(s): Dr Supriyo Choudhury, Professor Mark BakerORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Since its introduction as a treatment for strabismus, botulinum toxin (BoNT) has had a phenomenal journey and is now recommended as first-line treatment for focal dystonia, despite short-term clinical benefits and the risks of adverse effects. To cater for the high demand across various medical specialties, at least six US Food and Drug Administration (FDA)-approved formulations of BoNT are currently available for diverse labelled indications. The toxo-pharmacological properties of these formulations are not uniform and thus should not be used interchangeably. Synthetic BoNTs and BoNTs from non-clostridial sources are not far from clinical use. Moreover, the study of mutations in naturally occurring toxins has led to modulation in the toxo-pharmacokinetic properties of BoNTs, including the duration and potency. We present an overview of the toxo-pharmacology of conventional and novel BoNT preparations, including those awaiting imminent translation from the laboratory to the clinic.


Publication metadata

Author(s): Choudhury S, Baker MR, Chatterjee S, Kumar H

Publication type: Review

Publication status: Published

Journal: Toxins

Year: 2021

Volume: 13

Issue: 1

Print publication date: 14/01/2021

Online publication date: 14/01/2021

Acceptance date: 08/01/2021

ISSN (electronic): 2072-6651

Publisher: NLM (Medline)

URL: https://doi.org/10.3390/toxins13010058

DOI: 10.3390/toxins13010058

PubMed id: 33466571

Data Access Statement: Not applicable.


Share